WallStreetZenWallStreetZen

NASDAQ: WINT
Windtree Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

WINT past revenue growth

How has WINT's revenue growth performed historically?
Company
N/A
Industry
69.21%
Market
13.96%
WINT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
WINT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

WINT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$35.2M
Current Profit Margin
0%

WINT Return on Equity

Current Company
-262.3%
Current Industry
-17.9%
Current Market
30.8%
WINT's Return on Equity (-262.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when WINT announces earnings.

WINT Return on Assets

Current Company
-81.3%
Current Industry
1%
WINT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

WINT Return on Capital Employed

Current Company
-112.6%
Current Industry
14.2%
WINT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

WINT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
WINT$0.00-$35.95M-$35.19M-100.00%N/A
SILO$72.10k-$4.21M-$4.21M+91.44%N/A
BNTC$68.00k-$19.57M-$19.97M+75.81%N/A
AYTU$104.12M-$23.35M-$32.30M+96.31%N/A
XTLB$0.00-$1.35M-$1.35MN/AN/A
View Top Biotech Stocks

Windtree Therapeutics Earnings & Revenue FAQ

What were WINT's earnings last quarter?

On Invalid Date, Windtree Therapeutics (NASDAQ: WINT) reported Q1 2023 earnings per share (EPS) of -$4.76, up 66.85% year over year. Total Windtree Therapeutics earnings for the quarter were -$4.11 million. In the same quarter last year, Windtree Therapeutics's earnings per share (EPS) was -$14.36.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

What was WINT's earnings growth in the past year?

As of Q2 2023, Windtree Therapeutics's earnings has grown year over year. Windtree Therapeutics's earnings in the past year totalled -$35.19 million.

What was WINT's revenue last quarter?

On Invalid Date, Windtree Therapeutics (NASDAQ: WINT) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Windtree Therapeutics's revenue was $0.00.

What was WINT's revenue growth in the past year?

As of Q2 2023, Windtree Therapeutics's revenue has grown null year over year. Windtree Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.